Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 6 de 6
Filtrer
Plus de filtres











Gamme d'année
1.
Sci Adv ; 6(49)2020 12.
Article de Anglais | MEDLINE | ID: mdl-33268375

RÉSUMÉ

MicroRNAs (miRNAs) have been implicated in oxidative metabolism and brown/beige adipocyte identity. Here, we tested whether widespread changes in miRNA expression promoted by treatment with the small-molecule enoxacin cause browning and prevent obesity. Enoxacin mitigated diet-induced obesity in mice, and this was associated with increased energy expenditure. Consistently, subcutaneous white and brown adipose tissues and skeletal muscle of enoxacin-treated mice had higher levels of markers associated with thermogenesis and oxidative metabolism. These effects were cell autonomous since they were recapitulated in vitro in murine and human cell models. In preadipocytes, enoxacin led to a reduction of miR-34a-5p expression and up-regulation of its target genes (e.g., Fgfr1, Klb, and Sirt1), thus increasing FGF21 signaling and promoting beige adipogenesis. Our data demonstrate that enoxacin counteracts obesity by promoting thermogenic signaling and inducing oxidative metabolism in adipose tissue and skeletal muscle in a mechanism that involves, at least in part, miRNA-mediated regulation.


Sujet(s)
Énoxacine , microARN , Tissu adipeux brun/métabolisme , Animaux , Métabolisme énergétique , Énoxacine/métabolisme , Énoxacine/pharmacologie , Souris , Souris de lignée C57BL , microARN/génétique , microARN/métabolisme , Obésité/étiologie , Obésité/génétique , Stress oxydatif , Thermogenèse/génétique
2.
Pharmazie ; 64(2): 116-22, 2009 Feb.
Article de Anglais | MEDLINE | ID: mdl-19320285

RÉSUMÉ

We synthesized and determined the production of reactive oxygen species (ROS) as 1O2, *-O2, *OH, H2O2 during the photolysis with UV-A light of three antibacterial quinolones and their naphthyl ester derivatives. Singlet oxygen and ROS dose-dependant generation from norfloxacin (1), enoxacin (2), ciprofloxacin (3) and their respective naphthyl ester derivatives 4-6 were detecting in cell-free systems by the histidine assay and by luminol-enhanced chemiluminescence (LCL). Both the electronic absorption and emission spectra were quantified and their photostability determined. The antibacterial activity in darkness and under irradiation of compounds 4, 5 and 6 was tested on E. coli and compared with their parent drugs.


Sujet(s)
Antibactériens/pharmacologie , Fluoroquinolones/pharmacologie , Naphtalènes/pharmacologie , Oxydants photochimiques/pharmacologie , Antibactériens/effets des radiations , Ciprofloxacine/pharmacologie , Ciprofloxacine/effets des radiations , Milieux de culture , Énoxacine/pharmacologie , Énoxacine/effets des radiations , Escherichia coli/effets des médicaments et des substances chimiques , Escherichia coli/effets des radiations , Fluoroquinolones/effets des radiations , Histidine/analyse , Peroxyde d'hydrogène/composition chimique , Concentration en ions d'hydrogène , Luminescence , Norfloxacine/pharmacologie , Norfloxacine/effets des radiations , Oxydants/composition chimique , Photolyse , Photosensibilisants/pharmacologie , Espèces réactives de l'oxygène/composition chimique , Spectrométrie de fluorescence , Spectrophotométrie UV , Rayons ultraviolets
3.
Exp Parasitol ; 116(4): 475-82, 2007 Aug.
Article de Anglais | MEDLINE | ID: mdl-17466980

RÉSUMÉ

Certain model inhibitors exerted selective action against the catalytic activity of nuclear DNA topoisomerase II (TOPII) of Leishmania panamensis promastigotes. The second-generation fluoroquinolones enoxacin and ciprofloxacin exhibited extraordinarily high anti-parasite selectivity displaying 582- and 40-fold greater potencies against L. panamensis TOPII as compared with the human macrophage enzyme. The flavonoids quercetin and ellagic acid showed inverse specificities, the former being 161-fold more potent against L. panamensis TOPII, and the latter 15.7-fold more active against macrophage TOPII. The protoberberine coralyne was a potent inhibitor of both Leishmania and macrophage TOPII. Bis-benzimidazoles and the diamidine diminazene aceturate exhibited uniformly high potencies against parasite and host TOPII, but a second diamidine pentamidine showed 17.6-fold greater specificity for Leishmania TOPII. The antimonial sodium stibogluconate was an ineffective inhibitor of parasite TOPII showing 4.3-fold greater potency against the macrophage enzyme. These findings suggest that the leishmanicidal activities of certain fluoroquinolones and pentamidine may be mediated partly through TOPII inhibition.


Sujet(s)
Anti-infectieux/pharmacologie , Flavonoïdes/pharmacologie , Fluoroquinolones/pharmacologie , Leishmania guyanensis/enzymologie , Pentamidine/pharmacologie , Inhibiteurs de la topoisomérase-II , Animaux , Antiprotozoaires/pharmacologie , Lignée cellulaire , Noyau de la cellule/enzymologie , Ciprofloxacine/pharmacologie , Acide ellagique/pharmacologie , Énoxacine/pharmacologie , Humains , Concentration inhibitrice 50 , Leishmania guyanensis/effets des médicaments et des substances chimiques , Macrophages/enzymologie , Quercétine/pharmacologie
4.
J Parasitol ; 91(6): 1474-9, 2005 Dec.
Article de Anglais | MEDLINE | ID: mdl-16539034

RÉSUMÉ

We have demonstrated that fluoroquinolones, a class of antibacterial agents that act through inhibition of type II DNA topoisomerases, exert selective action against intracellular amastigotes of Leishmania (Viannia) panamensis at concentrations that are achievable in vivo. Drug cytotoxicity assays employing the luciferase reporter gene revealed that intracellular amastigotes were 6.6- to 25.9-fold more sensitive than human macrophages (P < 0.05) to second-generation fluoroquinolones in vitro. The most selective agents (enoxacin and ciprofloxacin) exhibited 2 orders of magnitude greater potency against parasites (50% effective dose [ED50] = 54.9-83.4 microM) than host cells (ED50 = 1,425-1,740 microM). Linear regression analysis of ED50 data confirmed a complete lack of correlation (r = 0.001) between the relative drug sensitivities of parasites and host cells. A potential relationship between the structures of fluoroquinolones and their relative leishmanicidal activities was observed. The key substituents of the basic pyridone beta-carboxylic acid nucleus accounting for enhanced antiparasite potency and selectivity appear to be a nitrogen at position 8 of the bicyclic nucleus (enoxacin), a cyclopropyl substituent at the R1 site (ciprofloxacin), and linkage of the R1 and X8 groups by a CH3CHO bridge to form a tricyclic compound (ofloxacin). These findings support the potential of fluoroquinolones and derivatives as novel antileishmanials and encourage their clinical evaluation.


Sujet(s)
Fluoroquinolones/pharmacologie , Leishmania guyanensis/effets des médicaments et des substances chimiques , Macrophages/parasitologie , Animaux , Lignée cellulaire , Cinoxacine/pharmacologie , Ciprofloxacine/pharmacologie , Énoxacine/pharmacologie , Humains , Macrophages/effets des médicaments et des substances chimiques , Acide nalidixique/pharmacologie , Norfloxacine/pharmacologie , Ofloxacine/pharmacologie , Quinolinone/pharmacologie
5.
Cuad. cir ; 8(1): 26-30, 1994. tab
Article de Espagnol | LILACS | ID: lil-207338

RÉSUMÉ

Escherichia coli es uno de los bacilos gram negativos más aislados en nuestras clínicas, provocando diversos cuadros de tipo infeccioso. Por este motivo es importante conocer la susceptibilidad antimicrobiana de esta especie, con el fin de poder administrar drogas antimicrobianas realmente efectivas. Este trabajo determina la sensibilidad cuantitativa "in vitro" de 245 cepas de Escherichia coli, aisladas de diversas muestras clínicas frente a 13 drogas antimicrobianas para lo cual se utilizó el método de dilución en agar de Ericsson y Sherris. Los resultados obtenidos muestran que alrededor del 90 por ciento de las cepas fueron sensibles a Enoxacino, Cefotaxima, Aztreonam, Gentamicina, Ceftriaxzona, Amikacina, Cefuroximo, Cefoperazona y Nitrofurantoina y alrededor del 50 por ciento de las cepas fueron sensibles a Cefradina. Frente a los restantes antimicrobianos-Cloramfenicol, Cotrimoxazol y Ampicilina- se obtuvo un alto nivel de resistencia


Sujet(s)
Antibactériens/pharmacologie , Infections à Escherichia coli/traitement médicamenteux , Escherichia coli/effets des médicaments et des substances chimiques , Techniques in vitro , Amikacine/pharmacologie , Ampicilline/pharmacologie , Aztréonam/pharmacologie , Céfopérazone/pharmacologie , Céfotaxime/pharmacologie , Ceftriaxone/pharmacologie , Céfuroxime/pharmacologie , Céfradine/pharmacologie , Chloramphénicol/pharmacologie , Résistance microbienne aux médicaments , Énoxacine/pharmacologie , Gentamicine/pharmacologie , Tests de sensibilité microbienne , Nitrofurantoïne/pharmacologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE